Cloud Banner

Pharmaceutical

Image

Global Deep Vein Thrombosis (DVT) Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Aug 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Deep Vein Thrombosis (DVT) Treatment Market, By Drugs Class (Anticoagulants, Heparin, Others), Treatment (Surgery, Drugs, Others), Mode of Administration (Injectable, Oral, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Homecare, Specialty Clinics, Others) - Industry Trends and Forecast to 2030.

Deep Vein Thrombosis (DVT) Treatment Market

Deep Vein Thrombosis (DVT) Treatment Market Analysis and Size

The Global Deep Vein Thrombosis (DVT) Treatment Market is rising steadily as a result of the increasing incidence of deep vein thrombosis. Growing R&D activities is considerably driving the global deep vein thrombosis (DVT) treatment market. Strategic initiatives by the key market players are one of the elements driving the market's rapid rise. Market players are expanding their product offerings in order to acquire a competitive advantage.

Data Bridge Market Research analyses that the global deep vein thrombosis (DVT) treatment market which was USD 627.43 in 2022, would rocket up to USD 1,394.36 Million by 2030, and is expected to undergo a CAGR of 9.5% during the forecast period. This indicates the market value. “Anticoagulants” dominates the drugs class segment of the Global Deep Vein Thrombosis (DVT) Treatment Market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Deep Vein Thrombosis (DVT) Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Drugs Class (Anticoagulants, Heparin, Others), Treatment (Surgery, Drugs, Others), Mode of Administration (Injectable, Oral, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Homecare, Specialty Clinics, Others)

Countries Covered

U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa

Market Players Covered

Aspen Holdings (South Africa), Novartis AG (Germany), Mylan N.V. (U.S.), Momenta Pharmaceuticals, Inc. (U.S.), Hikma Pharmaceuticals PLC (UK), Laboratorios FarmaceuticosRovi, S.A. (Spain), GL Pharma (Austria), Cobapharma (Barcelona), BoehringerIngelheim GmbH (Germany), Glenmark Pharmaceuticals Inc.(India), Bristol-Myers Squibb Company (U.S.), Portola Pharmaceuticals, Inc.(U.S.) Daiichi Sankyo Company, Limited (Japan), Johnson & Johnson Services, Inc. (U.S.), Bayer AG (Germany), Bausch Health (Canada), VasudhaPharma (India), Tianyu Pharmaceutical Co., Ltd.(China), Neuland Laboratories Ltd (India), and Mitsubishi Tanabe Pharma Corporation (Japan)

Market Opportunities

  • Product Innovations and Pipeline Developments
  • Increasing focus on improving healthcare infrastructure

Market Definition

The deep vein thrombosis (DVT) treatment refers to the market for products and therapies used in the diagnosis, prevention, and treatment of deep vein thrombosis—a medical condition characterized by the formation of blood clots in deep veins, typically in the legs. DVT can lead to serious complications, such as pulmonary embolism if not promptly diagnosed and treated. The market encompasses a wide range of treatment options, including medications (such as anticoagulants), medical devices (such as compression stockings, filters, and catheters), surgical interventions, and non-invasive procedures. It also includes diagnostic tools and tests used for the early detection and monitoring of DVT. The market is driven by factors such as the increasing prevalence of risk factors, advancements in diagnosis and treatment technologies, and growing awareness among healthcare professionals and the general population about the importance of early detection and timely management of DVT.

Global Deep Vein Thrombosis (DVT) Treatment Market Dynamics

Drivers

Increasing Incidence of Deep Vein Thrombosis

The incidence of deep vein thrombosis is rising globally due to factors such as sedentary lifestyles, obesity, the aging population, and the prevalence of risk factors like smoking and diabetes. This drives the demand for DVT treatment options.

Growing Awareness and Early Diagnosis

There is an increasing awareness of the signs, symptoms, and risks associated with DVT among healthcare professionals and the general population. Early diagnosis and timely treatment can prevent complications and improve patient outcomes, leading to a higher demand for DVT treatment.

Opportunities

Product Innovations and Pipeline Developments

There is a continuous focus on developing new and improved treatment options for DVT. Companies are investing in research and development to introduce innovative drugs, medical devices, and therapies that provide better efficacy, safety, and patient convenience.

Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, the rising number of market players will further expand the market's growth rate in the future.

Restraints/Challenges

On the other hand, the high cost associated with product manufacturing is expected to obstruct market growth. Also, the disruption in the supply chain industry has the potential to challenge the market’s growth. Also, the lack of favorable reimbursement scenarios and technology penetration in the developing economies, and lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.

This global deep vein thrombosis (DVT) treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global deep vein thrombosis (DVT) treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In June 2021, FDA approved first oral blood thinner, called Pradaxa (dabigatran etexilate) to treat children of age 3 months to 12 years with DVT.

Global Deep Vein Thrombosis (DVT) Treatment Market Scope​​​​​​​

The global deep vein thrombosis (DVT) treatment market is segmented on the basis of drugs class, treatment, mode of administration, distribution channel, and end-user. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drugs Class

  • Anticoagulants
  • Heparin
  • Others

Treatment

  • Surgery
  • Drugs
  • Others

Mode Of Administration

  • Injectable
  • Oral
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

End-User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Global Deep Vein Thrombosis (DVT) Treatment Market Regional Analysis/Insights

Global Deep Vein Thrombosis (DVT) Treatment Market is analyzed, and market size insights and trends are provided by drugs class, treatment, mode of administration, distribution channel, and end-user as referenced above.

The countries covered in the Global Deep Vein Thrombosis (DVT) Treatment Market report are U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa.

North America dominates the market due to factors including rising healthcare costs, increased R & D related to deep vein thrombosis treatment, and trending technological advancements.

Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 because of the rising strategic initiatives by the key market players and favourable government initiatives in the region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and the challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global deep vein thrombosis (DVT) treatment market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kind of products for the global deep vein thrombosis (DVT) treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global deep vein thrombosis (DVT) treatment market. The data is available for the historic period 2015-2020.

Competitive Landscape and Deep Vein Thrombosis (DVT) Treatment Market Share Analysis

The global deep vein thrombosis (DVT) treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global deep vein thrombosis (DVT) treatment market.

Some of the major players operating in the global deep vein thrombosis (DVT) treatment market are:

  • Aspen Holdings (South Africa)
  • Novartis AG (Germany)
  • Mylan N.V. (U.S.)
  • Momenta Pharmaceuticals, Inc. (U.S.)
  • Hikma Pharmaceuticals PLC (UK)
  • Laboratorios FarmaceuticosRovi, S.A. (Spain)
  • GL Pharma (Austria)
  • Cobapharma (Barcelona)
  • BoehringerIngelheim GmbH (Germany)
  • Glenmark Pharmaceuticals Inc.(India)
  • Bristol-Myers Squibb Company (U.S.)
  • Portola Pharmaceuticals, Inc.(U.S.)
  • Daiichi Sankyo Company, Limited (Japan)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Bayer AG (Germany)
  • Bausch Health (Canada)
  • VasudhaPharma (India)
  • Tianyu Pharmaceutical Co., Ltd.(China)
  • Neuland Laboratories Ltd (India)
  • Mitsubishi Tanabe Pharma Corporation (Japan)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The deep vein thrombosis (DVT) treatment market value will be USD 1,394.36 Million by 2030.
The growth rate of the deep vein thrombosis (DVT) treatment market is 9.5% by 2030.
Drugs class, treatment, mode of administration, distribution channel, and end-user are the factors on which the deep vein thrombosis (DVT) treatment market research is based.
Increasing Incidence of Deep Vein Thrombosis & Growing Awareness and Early Diagnosis are the growth drivers of the deep vein thrombosis (DVT) treatment market.
The latest development in the deep vein thrombosis (DVT) treatment market is - FDA approved first oral blood thinner, called Pradaxa (dabigatran etexilate) to treat children of age 3 months to 12 years with DVT.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials